Eplerenone inhibits aldosterone-induced renal expression of cyclooxygenase.

Journal of the Renin-angiotensin-aldosterone System : JRAAS
Ma BayorhDanita Eatman

Abstract

The upregulation of cyclooxygenase (COX) expression by aldosterone (ALDO) or high salt diet intake is very interesting and complex in the light of what is known about the role of COX in renal function. Thus, in this study, we hypothesize that apocynin (APC) and/or eplerenone (EPL) inhibit ALDO/salt-induced kidney damage by preventing the production of prostaglandin E₂ (PGE₂). Dahl salt-sensitive rats on either a low-salt or high-salt diet were treated with ALDO (0.2 mg pellet) in the presence of EPL (100 mg/kg/day) or APC (1.5 mM). Indirect blood pressure, prostaglandins and ALDO levels and histological changes were measured. Cyclooxygenase-2 (COX-2) levels were upregulated in the renal tubules and peritubular vessels after high-salt intake, and APC attenuated renal tubular COX-2 protein expression induced by ALDO. Plasma PGE₂ levels were significantly reduced by ALDO in the rats fed a low-salt diet when compared to rats fed a high-salt diet. PGE₂ was blocked by EPL but increased in the presence of APC. The beneficial effects of EPL may be associated with an inhibition of PGE₂. The mechanism underlying the protective effects of EPL is clearly distinct from that of APC and suggests that these agents can have differential roles i...Continue Reading

References

Nov 1, 1993·Annals of Surgery·M G Davies, P O Hagen
Sep 15, 1998·Kidney International. Supplement·R C HarrisJ A McKanna
Oct 18, 2000·The Journal of Biological Chemistry·A ShioseH Sumimoto
Oct 5, 2002·Hypertension·Agostino VirdisErnesto L Schiffrin
Nov 14, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Naris Thengchaisri, Lih Kuo
Mar 11, 2004·American Journal of Physiology. Renal Physiology·Alex PaliegeTianxin Yang
Jul 31, 2004·Acta Physiologica Scandinavica·R C HarrisH-F Cheng
Sep 17, 2004·The Journal of Clinical Investigation·Takayuki FujinoFumitaka Ushikubi
Feb 10, 2006·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·A PaliegeS Bachmann
Feb 21, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Wenyuan ZhaoYao Sun
Mar 21, 2006·Clinical and Experimental Hypertension : CHE·Mohamed A BayorhDanita Eatman
Jan 27, 2007·Current Diabetes Reports·Zhenqi Liu
Feb 13, 2007·Current Opinion in Nephrology and Hypertension·Anette FiebelerFriedrich C Luft
Aug 3, 2007·American Journal of Physiology. Renal Physiology·Hitesh PatniPravin C Singhal
Feb 11, 2009·Hypertension·Rui ZhangRuisheng Liu
Feb 5, 2011·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Mohamed A BayorhDanita Eatman

❮ Previous
Next ❯

Citations

Jun 15, 2015·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Jing XiaoZhibin Ye

❮ Previous
Next ❯

Methods Mentioned

BETA
protein assay

Software Mentioned

GraphPad
NIH Image

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.